It's time to fight
antimicrobial
resistance


IN ORDER TO PREVENT...

...the spread of antimicrobial resistant bacteria there needs to be a significant decrease in antibiotic use in wound care.

While the World Health Organisation is addressing AMR with a Global Action Plan, there is a lot of room to contribute to the prevention of AMR in the wound care sector.1 To be truly effective against AMR, action must be taken at every level of wound care, from wound specialists to wound nurses.

The European Wound Management Association recommends avoiding the unnecessary usage of antibiotics through adequate infection prevention/management and appropriate hygiene protocols.2

JOIN THE FIGHT AGAINST AMR

#WOUND_WARRIORS

THE WAY OF A WOUND WARRIOR

BECOME A WOUND WARRIOR AND JOIN THE FIGHT AGAINST ANTIMICROBIAL RESISTANCE

With the right tools for infection prevention and management in wound care, the unnecessary use of antibiotics may be avoidable. Through its brands, Cutimed® and Leukomed®, Essity offers a comprehensive range of wound care products that effectively prevent and manage infection with no known risk of further contributing to antimicrobial resistance.

  • The purely physical mode of action of Sorbact® technology effectively reduces the bacterial load and promotes wound healing
  • No known mechanism of resistance has been described
  • No additional release of endotoxins

FIGHT AGAINST AMR

APPROPIATE WOUND CARE FOR INFECTION PREVENTION AND INFECTION MANAGEMENT CAN PLAY A POWERFUL ROLE IN THE FIGHT AGAINST AMR

Cutimed® and Leukomed® offer an extensive range of effective products in wound management and infection control which may help avoid excessive use of antibiotics in wound care

SORBACT® TECHNOLOGY

Leukomed® Sorbact® and Cutimed® Sorbact® utilise the safe and effective Sorbact® technology that binds bacteria with a purely physical mode of action. Sorbact® Technology removes bacteria without releasing possibly harmful endotoxins3

INFECTION MANAGEMENT WITH CUTIMED®

Advanced chronic wound dressing for safe and effective wound management with a purely physical mode of action

SORBACT® BACTERIA-BINDING TECHNOLOGY
  • Safely binds bacteria and fungi
  • No known mechanism of resistance has been described

CUTIMED® SORBACT®

NEW NARRATIVE REVIEW SHOWS 4,044 PATIENTS WERE SUCCESSFULLY TREATED IN CLINICAL STUDIES WITH SORBACT® TECHNOLOGY4

#WOUND_WARRIORS

An antimicrobial stewardship initiative

LEUKOMED® SORBACT®

LEUKOMED® SORBACT® HAS DEMONSTRATED PROVEN EFFECTIVENESS IN VARIOUS CLINICAL STUDIES9, 10

  • Clinically significant 65% relative risk reduction of acquiring a surgical site infection post caesarean section9
  • Up to 57% cost reduction when treating caesarean sections, using NHS cost model11
  • Effective reduction of the bacterial burden in critically colonised or locally infected wounds12

Innovative surgical post-operative dressing for the reduction of bacterial colonisation with a purely physical mode of action.

Indications

All post/operative and traumatic wounds with dry to low exudate levels:

  • Surgical incisions
  • Lacerations, cuts, abrasions

JOIN THE FIGHT AGAINST AMR

#WOUND_WARRIORS

STAND UP AGAINST AMR

WITH A WIDE RANGE OF PRODUCTS INCLUDING SORBACT® TECHNOLOGY FOR PREVENTION AND INFECTION MANAGEMENT IN WOUND CARE, FROM ESSITY

REFERENCES

  1. World health Organisation, Global Action plan on antimicrobial resistance, May 2015.
  2. EWMA document: Antimicrobials and Non-healing Wounds.
  3. As shown in vitro; Susilo YB, Husmark J. DACC Coated. Wound Dressing and Endotoxin: Investigation on Binding Ability and Effect on Endotoxin Release from Gram-negative Bacteria. Poster presented at EWMA 2019.
  4. Mosti et al., Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study, Journal of Wound Care, 2015 Mar;24(3):121-2; 124-7.
  5. Chadwick and Ousey Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review journal of wound care Vol 28, No 6, June 2019.
  6. Stanirowski et al. Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section. Surg Infect (Larchmt). 2016 Aug;17(4):427-35.
  7. Totty et al., Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review, Vol 26, No 3, March 2017.
  8. Llungh et al Using the principle of hydrophobic interaction to bind and remove wound bacteria, Journal of Wound Care Vol 15, No 4, April 2006
  9. Stanirowski J, Bizon M, Cendrowski K, et al (2016b) Randomized controlled trial evaluating dialkylcarbomyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing caesarean section. Surg Infect (Larchmt) 17(4): 427 -35.
  10. Bua N, et al. Dlalkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017 Oct:44:387-392.
  11. Stanirowski PJ, Davies H, McMaster J, Mealing S, Sawicki W, Cendrowski K, Posnett J. Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section. J Wound Care. 2019 Apr 2;28(4):222-228.
  12. Cutting K, Maguire J (2015) Safe bioburden management. A clinical review of DACC technology. Journal of Wound Care Vol 24, No 5.
  13. JB4 40031810, In vitro evaluation of the cleansing effect of Cutimed® DebriClean and Cutisoft Cotton. August 2018, BSN medical data on file.
  14. JB4 40031908, In vitro evaluation of removal of viable biofilm by Cutimed® DebriClean and Cutisoft Cotton. August 2018, BSN medical data on file.
  15. JB4 40031811, In vitro evaluation of the bacterial adhesion to Cutimed® DebriClean and Cutisoft® Cotton. July 2018, BSN medical data on file.